Robert Dudley
No más puestos en curso
Fortuna: 3 078 $ al 31/03/2024
Perfil
Robert Michael Dudley was the founder of TransCode Therapeutics, Inc. (founded in 2016) where he held the titles of President, Chief Executive Officer & Director until 2024, and Artemes Technologies, Inc. (founded in 2012) where he held the titles of Chairman & Chief Executive Officer until 2015.
He also worked as an Associate at Harvard Medical School from 1973 to 1975.
Dudley received his undergraduate degree from Kent State University (Ohio).
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 13/12/2023 | 4 507 ( 0.07% ) | 3 078 $ | 31/03/2024 |
Antiguos cargos conocidos de Robert Dudley.
| Empresas | Cargo | Fin |
|---|---|---|
| TRANSCODE THERAPEUTICS, INC. | Founder | 13/01/2024 |
| Artemes Technologies, Inc. | Chief Executive Officer | 01/10/2015 |
| Harvard Medical School | Corporate Officer/Principal | 01/12/1975 |
Formación de Robert Dudley.
| Kent State University (Ohio) | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| TRANSCODE THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
| Artemes Technologies, Inc. |
- Bolsa de valores
- Insiders
- Robert Dudley
